J
Jean Caudrelier
Researcher at University of Strasbourg
Publications - 47
Citations - 944
Jean Caudrelier is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Cryoablation & Percutaneous. The author has an hindex of 15, co-authored 47 publications receiving 668 citations.
Papers
More filters
Journal ArticleDOI
CIRSE Guidelines on Percutaneous Vertebral Augmentation
Georgia Tsoumakidou,Chow Wei Too,Guillaume Koch,Jean Caudrelier,Roberto Luigi Cazzato,Julien Garnon,Afshin Gangi +6 more
TL;DR: The present review gives the indications, contraindications, safety profile and outcomes of the existing percutaneous VAPs.
Journal ArticleDOI
Percutaneous image-guided cryoablation: current applications and results in the oncologic field
Roberto Luigi Cazzato,Julien Garnon,Nitin Ramamurthy,Guillaume Koch,Georgia Tsoumakidou,Jean Caudrelier,Francesco Arrigoni,Luigi Zugaro,Antonio Barile,Carlo Masciocchi,Afshin Gangi +10 more
TL;DR: The overall evidence base for PICA is weak, effectively restricting PICA to cases where standard therapy and RFA are unsuitable, and the benefits of this emerging technique will hopefully become more widely available to cancer patients in the future.
Journal ArticleDOI
Adjunctive Thermoprotection During Percutaneous Thermal Ablation Procedures: Review of Current Techniques
Julien Garnon,Roberto Luigi Cazzato,Jean Caudrelier,Maud Nouri-Neuville,Pramod Rao,Emanuele Boatta,Nitin Ramamurthy,Guillaume Koch,Afshin Gangi +8 more
TL;DR: Different techniques may be combined to achieve successful protection in locations with complex anatomy, and respective advantages/drawbacks are discussed.
Journal ArticleDOI
Complications of Percutaneous Bone Tumor Cryoablation: A 10-year Experience.
Pierre Auloge,Roberto Luigi Cazzato,Chloé Rousseau,Jean Caudrelier,Guillaume Koch,Pramod Rao,Jeanie Betsy Chiang,Julien Garnon,Afshin Gangi +8 more
TL;DR: Bone tumor cryoablation is safe, with a 2.5% rate of major complications, most commonly secondary fracture (1.2%).
Journal ArticleDOI
Percutaneous Image-Guided Screw Fixation of Bone Lesions in Cancer Patients: Double-Centre Analysis of Outcomes including Local Evolution of the Treated Focus
Roberto Luigi Cazzato,Guillaume Koch,Xavier Buy,Nitin Ramamurthy,Georgia Tsoumakidou,Jean Caudrelier,Vittorio Catena,Julien Garnon,Jean Palussière,Afshin Gangi +9 more
TL;DR: PIGSF is feasible for a wide range of oncologic patients, offering good short-term efficacy, acceptable complication rates, and rapid recovery, and requires close clinico-radiological surveillance.